
Phase 2 data show RAP-219 eases acute bipolar mania with significant YMRS gains and encouraging tolerability, setting the stage for FDA talks and phase 3 plans.
Lamotrigine has unique benefits that are often missed in practice. Learn when to use it-and when to avoid it-in this tutorial.